HERMINDER BOPARAI, O.D.
Corneal and Contact Management Optometrist in BELLEVUE, Washington. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
HERMINDER BOPARAI, O.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 890 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 890
- Part D claims, 2023
- 48%
- generic prescribing
- $54.8K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
HERMINDER BOPARAI, O.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about HERMINDER BOPARAI, O.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Washington
How Corneal and Contact Management Optometrist compares to other specialties among Washington providers
Corneal and Contact Management Optometrist share within Washington
Corneal and Contact Management Optometrist is one of the more visible NUCC categories in Washington
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
HERMINDER BOPARAI, O.D.'s 2023 MIPS final score plotted against the Corneal and Contact Management Optometrist national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Corneal and Contact Management Optometrist) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Corneal and Contact Management Optometrist US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Corneal and Contact Management Optometrist.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
HERMINDER BOPARAI, O.D. appears in the CMS NPPES registry as a Corneal and Contact Management Optometrist provider holding O.D. credentials at 1414 116TH AVE NE STE B, BELLEVUE, WA, 98004, with a listed phone of (425) 502-7922. NPI 1639190150 was issued on 07/21/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BOPARAI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 890 prescription claims written by this provider, covering 218 Medicare beneficiaries and totaling roughly $260K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Corneal and Contact Management Optometrist is a narrow specialty nationwide, with 1,549 enrolled providers across 52 states and an average of 235 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1639190150 |
|---|---|
| Specialty | Corneal and Contact Management Optometrist |
| Credentials | O.D. |
| Gender | Male |
| NPI Issued | 07/21/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm HERMINDER BOPARAI, O.D.'s current license status, disciplinary history, and board certifications with the Washington State Department of Health, Medical Quality Assurance Commission in Washington before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for HERMINDER BOPARAI, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$54.8K
Largest payer
Mallinckrodt Hospital Products Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Washington WMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 — they are NOT specific to HERMINDER BOPARAI, O.D.. To verify HERMINDER BOPARAI, O.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
52% brand-name claims vs 48% generic, on 890 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,394
- Total Day Supply
- 39,210
- Brand vs Generic
- 52% brand / 48% generic
- Brand Drug Cost
- $248K
- Generic Drug Cost
- $13K
- Antibiotic Claims
- 27
Patient Demographics
- Average Patient Age
- 77.7 years
- Avg HCC Risk Score
- 1.09
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What HERMINDER BOPARAI, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
251 claims
- Restasis 95
Restasis
95 claims
- Timolol Maleate 91
Timolol Maleate
91 claims
- Xiidra 63
Xiidra
63 claims
- Prednisolone Acetate 40
Prednisolone Acetate
40 claims
- Lumigan 39
Lumigan
39 claims
- Dorzolamide-Timolol 33
Dorzolamide-Timolol
33 claims
- Vyzulta 30
Vyzulta
30 claims
| Drug | Claims |
|---|---|
| Latanoprost | 251 |
| Restasis Cyclosporine | 95 |
| Timolol Maleate | 91 |
| Xiidra Lifitegrast | 63 |
| Prednisolone Acetate | 40 |
| Lumigan Bimatoprost | 39 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 33 |
| Vyzulta Latanoprostene Bunod | 30 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 28 |
| Cyclosporine | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Corneal and Contact Management Optometrist Overview
How HERMINDER BOPARAI, O.D. fits within the Corneal and Contact Management Optometrist landscape nationally.
HERMINDER BOPARAI, O.D.'s 890 claims are above the specialty average of 235.
Nearby Corneal and Contact Management Optometrist Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as BOPARAI.
Compare Corneal and Contact Management Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Washington
Frequently Asked Questions
What is HERMINDER BOPARAI, O.D.'s specialty? ▼
How much does HERMINDER BOPARAI, O.D. prescribe under Medicare Part D? ▼
What is HERMINDER BOPARAI, O.D.'s Medicare quality score? ▼
Where is HERMINDER BOPARAI, O.D. located? ▼
What is HERMINDER BOPARAI, O.D.'s NPI number? ▼
Does HERMINDER BOPARAI, O.D. prescribe more brand-name or generic drugs? ▼
How many Corneal and Contact Management Optometrist providers are there in the US? ▼
What drugs does HERMINDER BOPARAI, O.D. prescribe most often? ▼
Does HERMINDER BOPARAI, O.D. accept Medicare? ▼
How can I verify HERMINDER BOPARAI, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology